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A R T I C L E I N F O A B S T R A C T
Background: ST-elevation myocardial infarction (STEMI) is a life-threatening condition. STEMI condition 
accompanied by complications such as prolonged shock condition and become Acute Kidney Injury (AKI), it is still 
a question of whether to be treated conservatively or invasively. If PPCI was an option, how to prevent the 
worsening outcome is still an issue. We present the case of a woman, 53 years old with STEMI inferior onset 5 
hours underwent PCI in acute kidney injury condition caused by cardiogenic shock. 
Objective: This study aimed to elaborate the safety of Primary Percutaneous Coronary Intervention in ST-Eleva-
tion Myocardial Infarction with Acute Kidney injury caused by Cardiogenic Shock
Case Presentation: A 53 years old, woman, was referred from a private hospital with STEMI inferior Killip IV onset 
5 hours with typical chest pain and azotemia. Creatinine serum was 3.4 mg/dl; eGFR 15 ml/m/1.73m2. Blood 
Gas Analyses show metabolic acidosis uncompensated. In the emergency room, she got hydration and inotropic 
drugs.  After the PCI procedure, she was fallen into an altered mental status and shock condition. The laboratori-
um result in our hospital showed improvement of creatinine level to 1.6 mg/dl. We treated this patient for 9 days, 
with optimal medicaments and fluid therapy. On the last day of treatment, there is an improvement in clinical 
presentation and laboratorium results.
Conclusion: Acute renal failure is a frequent complication in STEMI, leading to higher mortality, morbidity, and 
intrahospital complications. PPCI is a reperfusion strategy recommended by the guideline in the setting of 
myocardial infarction with cardiogenic shock. Proper management to prevent worsening of renal function in this 
condition is very important.    
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 ST-elevation myocardial infarction (STEMI) is a life-threat-
ening condition, defined by characteristic symptoms of myocardial 
ischemia in association with ST-segment elevation in two contiguous 
lead of electrocardiogram (EKG) and elevation of the cardiac marker. 
Its frequency is increasing, with 1-year mortality approximately 10%. In 
the presentation of cardiogenic shock, the mortality rate remains high 
at 40-50%. Delays in reperfusion for direct-presenting patients were 
associated with higher mortality.1,2  AKI is characterized by a dysfunc-
tion of structure and function of the kidney acutely. AKIN (Acute 
Kidney Injury Network) and KDIGO (Kidney Disease Improving Global 
Guidelines) define AKI as a percentage increase in serum creatinine of 
more than or equal to 50% (1.5-fold from baseline), with or without 
oliguria.3 
 AKI is a frequent complication in STEMI patients,  leading to 
higher morbidity, mortality, bleeding complications, and prolonged 
hospitalization.4,5 The incidence of AKI in STEMI patients ranges from 
5% to 30%, more than 33 % in cardiogenic shock, more often in women 
than men (10.5 % vs 7.8%).6,7 Some studies showed that  STEMI 
patients who underwent PPCI in acute kidney injury conditions were 
associated with a higher mortality rate and renal function worsening. 
CADILLAC study showed that the 30-day mortality rate was 16% in 
patients with AKI compared to 1 % in those without AKI. On the other 
side, in the setting of STEMI with cardiogenic shock, PPCI can improve 
renal perfusion and renal function.  An accurate clinical assessment is 
needed according to each patient's condition to determine the appropri-
ate treatment option. Management pre, during, and post-procedure 
related to outcome.8 
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 This case demonstrates that STEMI conditions complicated 
with prolonged shock and AKI stage 3 could have a better outcome if 
treated appropriately.  
2. Case Presentation
 A 53 years old, woman, was referred to a capable PCI 
hospital from a private hospital with STEMI inferior. She was already 
admitted to a private hospital due to nausea and vomiting and was 
diagnosed with gastritis. The ECG showed a normal sinus rhythm. In 
the middle night, she felt chest pain, typical, with worsening of nausea
42
Figure 1. (A) EXG before PPCI shows STEMI  Inferior (B) ECG iafter PPCI, ST-elevation in inferior lead was back to baseline, with T inverted.
(B)
(A)
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and vomiting accompanied by cold sweating, duration > 30 minutes, 
didn’t relieve by rest. At the time, the ECG was performed and showed 
STEMI inferior. Laboratorium result show mild leukocytosis, 
12.700/µL, Ureum 68 mg/dL, creatinine 3.4 mg/dL, with eGFR 15 
ml/m/1.73m2. There were cardiomegaly and minimal pleural effusion 
in hemithorax Sinistra on the CXR view. Then she was referred to a 
capable PCI hospital for revascularization. When she arrived, the 
systolic blood pressure was found at 70 mmHg; blood gas analyses 
show severe metabolic acidosis (PH 7.0, pCO2 20.2, pO2 94, bicarbon-
ate 5.3, base excess -26, SaO2 93%). She was given 250 ml of normal 
saline and an inotropic agent.  Echocardiography findings were left 
ventricle dilatation with LV eccentric hypertrophy, ejection fraction was 
22%, impaired relaxation, normal RV function, and valve.  Primary PCI 
was performed in the early morning, using about 100cc of contrast. 
Two DES was implanted in the osteal proximal Right Coronary Artery 
(RCA) and distal RCA. After PPCI, hemodynamic was more stable with 
hydration 1 cc/kg BW/hour and inotropic agent. During observation in 
the intensive care unit, she becomes delirious and was referred to RSSA 
for further management. Laboratorium findings after PPCI show 
improvement in renal function with Ureum 48.3 mg/dL, creatinine 1.64 
mg, dL, and eGFR 35 ml/m/1.73m2. Blood gas analyses show metabol-
ic acidosis fully compensated (pH 7.35, pCO2 25.1, pO2 140, bicarbon-
ate 14, base excess -12, SaO2 99%). 
 During two days of follow-up at the cardiovascular intensive 
care unit, the patient still complained about intermittent nausea and 
vomiting, hemodynamic relative stable with tapering off of inotropic 
agents. She got hydration IVFD NS 0.9% 1 cc/kg BW/hour. Urine 
output was 1600 cc/day, equal fluid balance. BGA results show 
improvement compared to the previous one, with acidosis metabolic 
fully compensated  (pH 7.34, pCO2 34.6, pO2 119, bicarbonate 19, 
base excess -6.9, SaO2 98.4%). Renal function also found to be 
improved with Ureum  was 23.5 mg/dL, creatinine was 1.29 mg/dL, 
and eGFR 47 ml/m/1.73m2. 
 During follow-up in the ward, she complains about intermit-
tent vomiting; hemodynamic was stable, urine output was 1700-1900 
cc/24 hours with equal to -100 cc/24 hours balance. Ureum was 8.2 
mg/dL, creatinine 0.8 mg/dL and GFR 84 ml/m/1.73m2. The patients 
improved both clinically and laboratory findings.  
3. Discussion 
 STEMI is a life-threatening condition caused by acute 
occlusion in the coronary artery. This condition leading to serious 
complication and need right and prompt treatment.9 STEMI was 
diagnosed based on consistent symptoms of myocardial ischemic such 
as persistent chest pain and elevation of the ST-T segment in at least 
two contiguous leads in ECG. Revascularization with PCI is a standard 
procedure recommended by guidelines. Cardiogenic shock is one of the 
frequent complications in STEMI, characterized by decreased cardiac 
output, leading to organ hypoperfusion and hypoxemia.2 In this case, 
the patient suffered from STEMI complicated with cardiogenic shock 
characterized by hypotension, cold acral, altered mental status, and 
acute kidney injury.
 The etiology of acute kidney injury was grouped into three 
groups, prerenal, renal, and post renal. A prerenal condition character-
ized by a decrease in renal perfusion due to hypovolemia includes renal 
losses, impaired cardiac output or low output states, and peripheral 
vasodilatation. Renal achieves up to 25% of total cardiac output. 
Inadequate renal perfusion leads to impairment of renal function 
without damage in the parenchymal. Damage in renal structure also 
can lead to acute renal failure. Acute tubular necrosis, glomerulone-
phritis, interstitial damage, and injury to intrarenal vessels lead to 
impairment renal structure and function. Post renal conditions are
characterized by obstruction in urinary flow. This condition increases 
intratubular pressures and thus decreases GFR. The inflammation 
process also contributes to diminished GFR.10 In this patient, acute 
kidney injury is a prerenal condition caused by a low cardiac output 
state because of myocardial infarction.
 AKI in STEMI patients was a consequence of acute cardiac 
condition and its treatment.  The incidence is increasing in the elderly, 
hypertension, and diabetic population. Acute cardiac conditions, such 
as hemodynamic changes, arrhythmia, and increased sympathetic 
activation, directly reduce renal arterial blood flow.  Of note, factors 
reflecting hemodynamic impairment such as reduced ejection fraction 
and high end-diastolic pulmonary arterial blood pressures are indepen-
dent AKI factors. Low EF also can induce intrarenal vasoconstriction 
and increase renal medullary necrosis.
 Furthermore, increased thrombogenicity during acute 
coronary syndromes and microemboli during a cardiac catheterization 
may also contribute to renal damage.  During STEMI, enhanced inflam-
matory response and increase oxidative stress synergistically accelerat-
ed the development of AKI. The other renal damage mechanism in 
STEMI treatment is contrasted with associated kidney injury 
(CA-AKI).11   
 This patient setting is a complicated situation. She was in a 
life-threatening condition with STEMI and cardiogenic shock. This 
condition complication in low renal perfusion and causing acute kidney 
injury. Previous nausea and vomiting worsen the condition. She also 
may suffer from depletion of intravascular volume due to low intake.  
Besides, the risk factor of renal failures such as hypertension and DM 
also plays a role in worsening renal function in this patient. 
 As the recommended procedure by guideline, primary PCI 
has a benefit and risk if done in AKI condition. It also can lead to 
worsening renal failure due to contrast-associated kidney injury. Some 
studies predict that PPCI in AKI baseline condition leads to higher 
mortality, prolonged hospitalization, and other complication.12,13 Both 
cardiac complications and noncardiac complications were higher in AKI 
populations. In the other side, some study shows that there was a 
benefit from PCI in the setting of acute kidney injury caused by cardio-
genic shock. Improvement in hemodynamic instability leads to 
improved renal perfusion, decreased creatinine level, and improved 
renal function.14–16 
 Guideline recommended that a decision on reperfusion 
strategy in renal dysfunction should be made as soon as possible, with 
an estimate of  GFR function. There are several ways to prevent worsen-
ing renal function due to PCI; optimal hydration pre, Durante, and 
post-procedural; adjusting antithrombotic drugs, using iso-osmolar 
contrast and a minimal amount of contrast agent. 2 A randomized study 
showed that intravascular volume expansion among myocardial 
infarction treated with PCI confers protection from contract-related 
AKI. Intravenous volume expansion, obtained immediately before 
primary PCI, although average (3 mL/kg in 1 hour) followed by 1 cc/kg 
BW/hour after procedure adjusted to EF, could partially compensate for 
reduced cardiac output and hypotension secondary to myocardial 
infarction and contribute to patient hemodynamic equilibrium (Figure 
2).17 Moreover, this can maintain renal perfusion in patients with 
depletion of intravascular volume caused by vomiting, diaphoresis, or 
decreased oral intake and hypovolemia.16 Another study reveals that 
rapid hydration in the emergency room before the PPCI procedure is 
significantly more effective than both no hydration or post-procedural 
hydration.11 
 In these patients, acute kidney injury resulted from a low 
cardiac output state due to myocardial infarction and cardiogenic 
shock. A reperfusion strategy with PCI is recommended. She underwent 
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PCI in high-risk conditions. We give hydration pre-procedural in ER 
with normal saline 0.9% about 250cc. Durante procedural, we give 
hydration 1 cc/kg BW/hour and using minimal contrast about 100cc 
iso-osmolar contrast. After the procedure, we continue the maintenance 
hydration of 1 cc/kg BW/hour. After PCI was performed, there is an 
improvement in general condition, both myocardial infarction and 
renal function. This condition is characterized by the improvement of 
clinical outcomes, urine production, and laboratory findings.
 In the study of Fox et al., bleeding risk, and complications 
after the procedure are related to AKI. The patient who experienced AKI 
has a higher femoral access-site bleeding, hematoma formations, and 
pseudoaneurysm compared to no AKI.13 AKI in STEMI is related to poor 
prognosis, both short term, and long term. In-hospital mortality and 
30-day mortality rate were higher in STEMI with AKI. In the long term, 
AKI onset following primary PCI was independently associated with a 
significant increase in death or dialysis's 2-year cumulative event rate.18 
Marenzi et al. show that renal function improvement after STEMI has a 
better prognosis than worsening renal failure. In this patient, there is an 
improvement in renal function after PPCI was performed.
3. Conclusion 
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 Acute renal failure is a frequent complication in STEMI, 
leading to higher mortality, morbidity, and intrahospital complications. 
PPCI is a reperfusion strategy recommended by the guideline in the 
setting of myocardial infarction with cardiogenic shock. Hydration and 
volume status pre, Durante, and post PPCI procedures play an import-
ant role in clinical outcome. Close fluid monitoring is needed in AKI 
condition post-PPCI complicate with reduced cardiac function to avoid 
overload.
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Age. Diabetes mellitus, e-GFR, 
anaemia, acute MI, CHF,  BP
High RiskModerate Risk
Consider alternative imaging modalities
Discontinue nephrotoxic medications for 48 jours and metformin for 
24 hours, consider high dose statin
Intravenous pre-hydration
NaCL 0.9% 1-1.5 ml/kg for 12 hours
or for elective patients
NaCL 0.9% or NaHCO3 1.26% 3 ml/kg for 1 hour
Intravenous post-hydration
NaCL 0.9% 1-1.5 ml/kg for 12 hours
or for elective patients
NaCL 0.9% or NaHCO3 1.26% 3 ml/kg for 1 hour
Repeat serum creatinine )SCr) at 48-72 hours CIN = >25% or >0.5 
mg/dl (44 µmol/L) rise in SCr 
Restart nephrotoxic medications/Metformin if no CIN
Use the lowest volume of IOCM or LOCM 
(<350 ml or < 4 ml/kg or V/CrCl < 3.7:1)
If necessary treat CIN as per AKI guidelines
Low Risk
Oral Hydration
Figure 2. Algorithm for the management of CIN. Adapted from Rear R, et al. Contrast induced nephropathy following angiography and cardiac 
interventions, bmj.journal,2016
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